Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study

September 25, 2025 updated by: Maastricht University Medical Center
Multicenter, retrospective cohort study investigating healthcare utilization in compensated and decompensated liver cirrhosis patients, including disease course and characteristics associated with healthcare utilization and, for example psychosocial factors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Netherlands
    • Gelderland
      • Apeldoorn, Gelderland, Netherlands, 7334 DZ
        • Recruiting
        • Gelre Ziekenhuizen
        • Contact:
    • Limburg
      • Maastricht, Limburg, Netherlands, 6202 AZ
        • Recruiting
        • Maastricht University Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with liver cirrhosis

Description

Inclusion Criteria:

  • Patients ≥ 18 years of age
  • Liver cirrhosis, based on biopsy, fibroscan or diagnostic imaging data

Exclusion Criteria:

  • Known malignancy with hepatic metastasis at baseline
  • Liver transplantation at baseline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of liver cirrhosis related outpatient contacts before liver cirrhosis complications
Time Frame: 2 years before complication, death or loss to follow-up
2 years before complication, death or loss to follow-up
Number of liver cirrhosis related radiographic imaging before liver cirrhosis complications
Time Frame: 2 years before complication, death or loss to follow-up
2 years before complication, death or loss to follow-up
Number of liver cirrhosis related esophagogastroscopies before liver cirrhosis complications
Time Frame: 2 years before complication, death or loss to follow-up
2 years before complication, death or loss to follow-up
Number of liver cirrhosis related elastographies before liver cirrhosis complications
Time Frame: 2 years before complication, death or loss to follow-up
2 years before complication, death or loss to follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maastricht University Medical Center

Collaborators

Gelre Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

May 23, 2023

First Submitted That Met QC Criteria

November 20, 2023

First Posted (Actual)

November 29, 2023

Study Record Updates

Last Update Posted (Estimated)

September 26, 2025

Last Update Submitted That Met QC Criteria

September 25, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-2857-A-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Cirrhosis

Clinical Trials on No intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe